Our technology

A revolution in drug discovery & development

Drug development is a complex, time-consuming and resource intensive process that often fails to cross the finish line.

Computer assisted drug design (CADD) has long failed to live up to it's promise to streamline that process and deliver truly insightful information to help design better drugs. HTuO's physics-based technology addresses the root of the issue.

Learn More

Our Mission

Minimizing the error of simulations

For protein scale simulations, it is imperative that the error introduced by approximations in the underlying force field be as small as possible, which is the goal of HTuO’s development process: to get ever closer to accurate simulations with minimal error.

About Us
HtuO Bioscience molecule

The HTuO advantage

Introducing high accuracy into modeling gives us and our partners the ability to address the challenges of drug design head-on. A more detailed understanding of how molecules interact allows for data-driven predictions of the best possible drug design - ultimately leading to fewer drugs failing and more efficacious drugs.

Icon discovery
Target Market

Learn more about our potential in the drug discovery & our long term vision.
Applications

Icon discovery
Collaboration

We are happy to discuss any form of a collaboration to let you access our platform.
Partnerships

Icon discovery
Careers

We are always on the lookout for talent. We’re open to fixed location and remote work. See Careers

Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions

Recent News & Events

October 9, 2024

Our Director of Business Development, Mr. Jacek Mis, will be in Stockholm, Sweden, Nov 3-6 at the 2024 BIO-Europe. Connect with Jacek through the partnering portal or email us directly to learn about HTuO and our drug discovery goals.

August 21, 2024

HTuO Biosciences announces appointment of Mr. Neil Klompas to its Board of Directors. Neil is currently the President and CEO of Augurex Life Sciences, and has over 20 years of experience in the pharmaceutical industry. Read the press release here.

July 26, 2024

Our scientists, Dr. Yi-Hsuan Lin and Dr. Ahmed Ayoub, will be attending the ACS Fall 2024 conference from August 18 to 22 in Denver, Colorado. They will be presenting two posters: one titled ‘AtomForge: Advances in the development of a novel polarizable and reactive force field (#4103171)’ and the other titled ‘AtomForge: a novel, reactive and polarizable force field for multi-scale simulations of small molecules and macromolecules in drug discovery (#4103302).

View All News & Events